WI
IONS icon

WrapManager Inc’s Ionis Pharmaceuticals IONS Stock Holding History

WrapManager Inc’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,668
Closed -$289K – 271
2024
Q1 		$289K Sell
6,668
-736
-10% -$35.1K 0.08% 206
2023
Q4 		$375K Sell
7,404
-123
-2% -$5.89K 0.11% 173
2023
Q3 		$341K Sell
7,527
-466
-6% -$19.2K 0.11% 170
2023
Q2 		$328K Sell
7,993
-680
-8% -$26.1K 0.1% 198
2023
Q1 		$310K Buy
8,673
+174
+2% +$6.53K 0.1% 212
2022
Q4 		$321K Sell
8,499
-334
-4% -$14K 0.1% 199
2022
Q3 		$391K Sell
8,833
-718
-8% -$30.3K 0.13% 164
2022
Q2 		$354K Sell
9,551
-163
-2% -$6.15K 0.11% 190
2022
Q1 		$360K Buy
9,714
+1,396
+17% +$45.7K 0.1% 204
2021
Q4 		$253K Sell
8,318
-2,006
-19% -$63.1K 0.06% 267
2021
Q3 		$346K Sell
10,324
-259
-2% -$9.76K 0.09% 209
2021
Q2 		$422K Buy
10,583
+71
+0.7% +$2.78K 0.11% 183
2021
Q1 		$473K Sell
10,512
-37
-0.4% -$2.06K 0.13% 159
2020
Q4 		$596K Sell
10,549
-552
-5% -$27.5K 0.17% 135
2020
Q3 		$527K Sell
11,101
-264
-2% -$14.7K 0.18% 130
2020
Q2 		$670K Sell
11,365
-1,217
-10% -$67.7K 0.25% 98
2020
Q1 		$595K Sell
12,582
-2,246
-15% -$125K 0.27% 99
2019
Q4 		$896K Sell
14,828
-970
-6% -$57.8K 0.28% 95
2019
Q3 		$946K Sell
15,798
-540
-3% -$35.2K 0.31% 87
2019
Q2 		$1.05M Buy
16,338
+255
+2% +$18K 0.34% 81
2019
Q1 		$1.3M Sell
16,083
-403
-2% -$26K 0.43% 61
2018
Q4 		$891K Sell
16,486
-361
-2% -$18.4K 0.32% 83
2018
Q3 		$869K Buy
16,847
+40
+0.2% +$1.88K 0.28% 110
2018
Q2 		$700K Sell
16,807
-1,053
-6% -$46.7K 0.23% 117
2018
Q1 		$787K Buy
17,860
+172
+1% +$8.74K 0.26% 98
2017
Q4 		$890K Sell
17,688
-690
-4% -$37.8K 0.29% 90
2017
Q3 		$932K Sell
18,378
-199
-1% -$10.4K 0.32% 79
2017
Q2 		$945K Buy
18,577
+553
+3% +$25.8K 0.33% 78
2017
Q1 		$725K Buy
18,024
+696
+4% +$31.3K 0.27% 89
2016
Q4 		$829K Buy
17,328
+4,430
+34% +$175K 0.32% 81
2016
Q3 		$473K Sell
12,898
-136
-1% -$4.25K 0.19% 109
2016
Q2 		$304K Buy
13,034
+594
+5% +$19.2K 0.13% 146
2016
Q1 		$504K Buy
12,440
+1,026
+9% +$41.7K 0.22% 100
2015
Q4 		$707K Buy
+11,414
New +$616K 0.34% 80

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
TBC
Tweedy, Browne Co Stamford, Connecticut $1.26B AUM 33.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

WrapManager Inc's IONS Position: Q2 2024 in Review

WrapManager Inc sold out of Ionis Pharmaceuticals (IONS) in Q2 2024, closing a stake of 6,668 shares — an estimated $289K sold.

WrapManager Inc first reported a position in IONS in Q4 2015 and held it in 34 quarters. The position peaked at $1.3M in Q1 2019. 356 funds tracked by Wall St. Rank hold IONS as of Q2 2024.

  • WrapManager Inc reported no remaining Ionis Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • WrapManager Inc sold 6,668 Ionis Pharmaceuticals shares in Q2 2024, an estimated $289K.
  • WrapManager Inc first reported a position in Ionis Pharmaceuticals in Q4 2015 and held it in 34 quarters.
  • WrapManager Inc's Ionis Pharmaceuticals position peaked at $1.3M in Q1 2019.
  • 356 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2024.

Based on WrapManager Inc's 13F filing for Q2 2024, filed 8 Aug 2024.